Logo image of CNM

CORE & MAIN INC-CLASS A (CNM) Stock Fundamental Analysis

NYSE:CNM - New York Stock Exchange, Inc. - US21874C1027 - Common Stock - Currency: USD

50.97  -1.45 (-2.77%)

After market: 50.97 0 (0%)

Fundamental Rating

5

Overall CNM gets a fundamental rating of 5 out of 10. We evaluated CNM against 48 industry peers in the Trading Companies & Distributors industry. CNM scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, CNM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year CNM was profitable.
In the past year CNM had a positive cash flow from operations.
Each year in the past 5 years CNM has been profitable.
CNM had a positive operating cash flow in 4 of the past 5 years.
CNM Yearly Net Income VS EBIT VS OCF VS FCFCNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

With a decent Return On Assets value of 6.60%, CNM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With an excellent Return On Equity value of 24.54%, CNM belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
CNM's Return On Invested Capital of 11.36% is fine compared to the rest of the industry. CNM outperforms 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CNM is above the industry average of 9.88%.
Industry RankSector Rank
ROA 6.6%
ROE 24.54%
ROIC 11.36%
ROA(3y)6.17%
ROA(5y)4.19%
ROE(3y)19.68%
ROE(5y)14.21%
ROIC(3y)12.93%
ROIC(5y)9.55%
CNM Yearly ROA, ROE, ROICCNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With a decent Profit Margin value of 5.71%, CNM is doing good in the industry, outperforming 60.42% of the companies in the same industry.
In the last couple of years the Profit Margin of CNM has grown nicely.
CNM has a better Operating Margin (9.93%) than 64.58% of its industry peers.
In the last couple of years the Operating Margin of CNM has grown nicely.
With a Gross Margin value of 26.63%, CNM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CNM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.93%
PM (TTM) 5.71%
GM 26.63%
OM growth 3Y29.72%
OM growth 5Y20.79%
PM growth 3Y65.47%
PM growth 5Y37.09%
GM growth 3Y4%
GM growth 5Y4.17%
CNM Yearly Profit, Operating, Gross MarginsCNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNM is creating some value.
Compared to 1 year ago, CNM has less shares outstanding
CNM has a worse debt/assets ratio than last year.
CNM Yearly Shares OutstandingCNM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
CNM Yearly Total Debt VS Total AssetsCNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.21 indicates that CNM is not in any danger for bankruptcy at the moment.
CNM's Altman-Z score of 3.21 is fine compared to the rest of the industry. CNM outperforms 68.75% of its industry peers.
The Debt to FCF ratio of CNM is 3.70, which is a good value as it means it would take CNM, 3.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNM (3.70) is better than 66.67% of its industry peers.
CNM has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
CNM's Debt to Equity ratio of 1.43 is on the low side compared to the rest of the industry. CNM is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.7
Altman-Z 3.21
ROIC/WACC1.05
WACC10.8%
CNM Yearly LT Debt VS Equity VS FCFCNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

CNM has a Current Ratio of 2.14. This indicates that CNM is financially healthy and has no problem in meeting its short term obligations.
CNM has a Current ratio of 2.14. This is comparable to the rest of the industry: CNM outperforms 54.17% of its industry peers.
CNM has a Quick Ratio of 1.28. This is a normal value and indicates that CNM is financially healthy and should not expect problems in meeting its short term obligations.
CNM's Quick ratio of 1.28 is in line compared to the rest of the industry. CNM outperforms 56.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.28
CNM Yearly Current Assets VS Current LiabilitesCNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CNM have decreased by -1.28% in the last year.
The Earnings Per Share has been growing by 60.95% on average over the past years. This is a very strong growth
The Revenue has grown by 8.24% in the past year. This is quite good.
CNM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.92% yearly.
EPS 1Y (TTM)-1.28%
EPS 3Y108.01%
EPS 5Y60.95%
EPS Q2Q%1.37%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y22.54%
Revenue growth 5Y15.92%
Sales Q2Q%11.55%

3.2 Future

The Earnings Per Share is expected to grow by 6.82% on average over the next years.
Based on estimates for the next years, CNM will show a small growth in Revenue. The Revenue will grow by 6.73% on average per year.
EPS Next Y-4.22%
EPS Next 2Y1.68%
EPS Next 3Y6.82%
EPS Next 5YN/A
Revenue Next Year10.34%
Revenue Next 2Y7.25%
Revenue Next 3Y6.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNM Yearly Revenue VS EstimatesCNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CNM Yearly EPS VS EstimatesCNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.06 indicates a rather expensive valuation of CNM.
Compared to the rest of the industry, the Price/Earnings ratio of CNM is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.62, CNM is valued a bit cheaper.
A Price/Forward Earnings ratio of 20.80 indicates a rather expensive valuation of CNM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, CNM is valued at the same level.
Industry RankSector Rank
PE 22.06
Fwd PE 20.8
CNM Price Earnings VS Forward Price EarningsCNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNM indicates a slightly more expensive valuation: CNM is more expensive than 60.42% of the companies listed in the same industry.
77.08% of the companies in the same industry are more expensive than CNM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.55
EV/EBITDA 13.96
CNM Per share dataCNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of CNM may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2Y1.68%
EPS Next 3Y6.82%

More info and screens

0

5. Dividend

5.1 Amount

CNM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE & MAIN INC-CLASS A

NYSE:CNM (2/21/2025, 8:10:23 PM)

After market: 50.97 0 (0%)

50.97

-1.45 (-2.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)12-03 2024-12-03/bmo
Earnings (Next)N/A N/A
Inst Owners104.47%
Inst Owner Change-91.04%
Ins Owners0.35%
Ins Owner Change-2.22%
Market Cap10.13B
Analysts77.65
Price Target62.36 (22.35%)
Short Float %6.88%
Short Ratio6.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.25%
Min EPS beat(2)-10.01%
Max EPS beat(2)12.5%
EPS beat(4)3
Avg EPS beat(4)2.28%
Min EPS beat(4)-10.01%
Max EPS beat(4)12.5%
EPS beat(8)7
Avg EPS beat(8)4.88%
EPS beat(12)11
Avg EPS beat(12)11.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2%
Min Revenue beat(2)-5.49%
Max Revenue beat(2)1.49%
Revenue beat(4)2
Avg Revenue beat(4)-1%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)1.49%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)6
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.27%
PT rev (3m)19.15%
EPS NQ rev (1m)3.56%
EPS NQ rev (3m)-11.71%
EPS NY rev (1m)0%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)1.87%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.37%
Valuation
Industry RankSector Rank
PE 22.06
Fwd PE 20.8
P/S 1.41
P/FCF 15.55
P/OCF 14.89
P/B 6.06
P/tB N/A
EV/EBITDA 13.96
EPS(TTM)2.31
EY4.53%
EPS(NY)2.45
Fwd EY4.81%
FCF(TTM)3.28
FCFY6.43%
OCF(TTM)3.42
OCFY6.72%
SpS36.16
BVpS8.41
TBVpS-5.92
PEG (NY)N/A
PEG (5Y)0.36
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 24.54%
ROCE 13.98%
ROIC 11.36%
ROICexc 11.38%
ROICexgc 25.83%
OM 9.93%
PM (TTM) 5.71%
GM 26.63%
FCFM 9.06%
ROA(3y)6.17%
ROA(5y)4.19%
ROE(3y)19.68%
ROE(5y)14.21%
ROIC(3y)12.93%
ROIC(5y)9.55%
ROICexc(3y)13.15%
ROICexc(5y)9.86%
ROICexgc(3y)32.43%
ROICexgc(5y)28.05%
ROCE(3y)15.91%
ROCE(5y)11.76%
ROICexcg growth 3Y10.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y41.37%
ROICexc growth 5YN/A
OM growth 3Y29.72%
OM growth 5Y20.79%
PM growth 3Y65.47%
PM growth 5Y37.09%
GM growth 3Y4%
GM growth 5Y4.17%
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.7
Debt/EBITDA 2.66
Cap/Depr 15.76%
Cap/Sales 0.4%
Interest Coverage 4.54
Cash Conversion 75.81%
Profit Quality 158.78%
Current Ratio 2.14
Quick Ratio 1.28
Altman-Z 3.21
F-Score3
WACC10.8%
ROIC/WACC1.05
Cap/Depr(3y)18.52%
Cap/Depr(5y)14.68%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.28%
EPS 3Y108.01%
EPS 5Y60.95%
EPS Q2Q%1.37%
EPS Next Y-4.22%
EPS Next 2Y1.68%
EPS Next 3Y6.82%
EPS Next 5YN/A
Revenue 1Y (TTM)8.24%
Revenue growth 3Y22.54%
Revenue growth 5Y15.92%
Sales Q2Q%11.55%
Revenue Next Year10.34%
Revenue Next 2Y7.25%
Revenue Next 3Y6.73%
Revenue Next 5YN/A
EBIT growth 1Y-4.93%
EBIT growth 3Y58.95%
EBIT growth 5Y40.02%
EBIT Next Year23.47%
EBIT Next 3Y12.89%
EBIT Next 5YN/A
FCF growth 1Y543.28%
FCF growth 3Y70.48%
FCF growth 5Y63.93%
OCF growth 1Y426.32%
OCF growth 3Y69.43%
OCF growth 5Y60.33%